Comparison of Subject-driven Titration of Biphasic Insulin Aspart (BIAsp) 30 Twice Daily Versus Investigator-driven Titration of BIAsp 30 Twice Daily Both in Combination With Oral Antidiabetic Drugs in Subjects With Type 2 Diabetes
Clinical trial NCT01618214 · COMPLETED
Trial details
- NCT number
- NCT01618214
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-01
- Primary completion
- 2013-01-01
- Enrollment
- 344
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.